Spectrum Health - Helen DeVos Children's Hospital

Clinical research site in Grand Rapids, Michigan · 1840 WEALTHY ST SE, GRAND RAPIDS, MI 49506-2921 · (616) 774-7230

As of July 2026, 15 paid clinical trials are recruiting at Spectrum Health - Helen DeVos Children's Hospital in Grand Rapids, Michigan. Active studies at this site cover conditions such as Colorectal Cancer, Pancreatic Ductal Adenocarcinoma and Prostate Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Spectrum Health - Helen DeVos Children's Hospital (15)

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

for Lumbar Spinal Stenosis

2343 locations incl. Athens

Sponsor: Stryker Instruments

Sex: All·Age: 18+

Code: NCT03072927·Recruiting·Listed Mar 2017

Apply to this trial

A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

for Primary Generalized Tonic-Clonic Seizures

51 locations incl. Mobile

Sponsor: Xenon Pharmaceuticals Inc.

Sex: All·Age: 12+

Code: NCT05667142·Phase 3·Recruiting·Listed Dec 2022

Apply to this trial

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

for Oligometastatic Prostate Cancer (OMPC)

40 locations incl. Fayetteville

Sponsor: Novartis Pharmaceuticals

Sex: Male·Age: 18 - 100

Code: NCT05939414·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

for Prostate Cancer

27 locations incl. Birmingham

Sponsor: Clarity Pharmaceuticals Ltd

Sex: Male·Age: 18+

Code: NCT06056830·Phase 3·Recruiting·Listed Sep 2023

Apply to this trial

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

for Urothelial Carcinoma Bladder

12 locations incl. Duarte

Sponsor: Aktis Oncology, Inc.

Sex: All·Age: 18+

Code: NCT07020117·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

for Neuroendocrine Tumors Unresectable

19 locations incl. Jacksonville

Sponsor: Perspective Therapeutics

Sex: All·Age: 18 - 90

Code: NCT05636618·Phase 1, Phase 2·Recruiting·Listed Dec 2022

Apply to this trial

Pompe Pregnancy Sub-Registry

for Glycogen Storage Disease Type II (GSD-II)

14 locations incl. Phoenix

Sponsor: Genzyme, a Sanofi Company

Sex: Female·Age: All ages

Code: NCT00567073·Recruiting·Listed Dec 2007

Apply to this trial

Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy

for Down Syndrome

12 locations incl. Birmingham

Sponsor: Sequenom, Inc.

Sex: Female·Age: 18+

Code: NCT01429389·Recruiting·Listed Sep 2011

Apply to this trial

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

for Castration Resistant Metastatic Prostate Cancer

4 locations incl. Irvine

Sponsor: Aktis Oncology, Inc.

Sex: Male·Age: 18+

Code: NCT07581184·Phase 1·Recruiting·Listed May 2026

Apply to this trial

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

for Colorectal Cancer

1 location in Grand Rapids

Sponsor: GE Healthcare

Sex: All·Age: 18+

Code: NCT07219238·Phase 2, Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

for Castration-Resistant Prostate Cancer (CRPC)

4 locations incl. Dothan

Sponsor: Radiopharm Theranostics, Ltd

Sex: All·Age: 18+

Code: NCT07189871·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

for Pancreatic Ductal Adenocarcinoma

9 locations incl. Birmingham

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT06562192·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

for Prostatic Neoplasms, Castration-Resistant

7 locations incl. Stanford

Sponsor: Clarity Pharmaceuticals Ltd

Sex: Male·Age: 18+

Code: NCT04868604·Phase 1, Phase 2·Recruiting·Listed May 2021

Apply to this trial

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for Hematologic Malignancies

113 locations incl. Birmingham

Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All·Age: All ages

Code: NCT01351545·Recruiting·Listed May 2011

Apply to this trial

HEALEY ALS Platform Trial - Master Protocol

for Amyotrophic Lateral Sclerosis

78 locations incl. Phoenix

Sponsor: Merit E. Cudkowicz, MD

Sex: All·Age: 18+

Code: NCT04297683·Phase 2, Phase 3·Recruiting·Listed Mar 2020

Apply to this trial

More research sites in Grand Rapids

Corewell Health Grand Rapids Hospitals - Butterworth Hospital (59 trials)
Trinity Health Grand Rapids Hospital (54 trials)
START Midwest (54 trials)
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital (52 trials)
Corewell Health (41 trials)
Helen DeVos Children's Hospital (16 trials)
BAMF Health (9 trials)
Helen DeVos Children's Hospital at Spectrum Health (8 trials)
START Midwest, LLC (8 trials)
Spectrum Health at Butterworth Campus (8 trials)

Explore more

Paid clinical trials in Grand Rapids, MI · Michigan clinical trials